| |
|
|
|
OncoSec Medical Incorporated  
|
|
1.95 -0.01 (-0.01%) |
07-10 16:00 |
|
Open: |
1.98 |
Pre close: |
1.96 |
Target:
|
2.73
|
|
High: |
1.99 |
Low: |
1.91 |
Resistance:
|
2.33
2.64
|
|
Volume: |
60,524 |
Market Cap: |
45M |
Support:
|
1.84
1.53
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.97
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
2.04 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.78  |
Stochastic Oscillator |
%K(14,3):
|
24.55 |
|
MA(250): |
1.94 |
%D(3): |
24.14 |
|
Average Volume(K) |
3-Month: |
24268
|
52-Week |
High:
|
2.97 |
|
10-Days: |
15172 |
Low: |
1.04 |
|
RSI |
RSI(14):
|
43.59 |
Change(%): |
-12.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.083 |
Return on Equity (ttm) |
-190.2 |
Shares Out. (M) |
23.03 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-76.2 |
Shares Float (M) |
9.18 |
|
EPS Est. Next Year |
-0.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
60.40 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.90 |
|
Forward EPS |
-4.290 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
134 |
|
Book Value (p.s.) |
0.950 |
EBITDA (p.s.) |
-1.741 |
P/E |
-0.63 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-31.88 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-15.71 |
P/CF |
-1.41 |
|
|
|
|
|
|
